Find News

Filter articles

Showing 3331 to 3340 of 3632 results

BIO 2014: US fears uncertainty over patent eligibility could drive innovation overseas


In a discussion about the implications of the US Supreme Court’s decisions on patent-eligible matter in Prometheus and Myriad at the BIO International Convention yesterday, entitled Patent eligibility from the trenches, an audience member expressed concern that uncertainty over patenting rules could drive American innovators overseas.

BIO 2014: Proper valuation of IP important in all sectors, says Rader


Learning to determine the value technological advance has contributed requires a great degree of sophistication, Randall Rader said in a session on protecting biotechnology innovations in the US and Latin America at the 2014 BIO International Convention in San Diego, California, yesterday (Tuesday).

BIO 2014: Patent community hopeless at compliance, Gurry says


The whole international patent community has been reasonably good at developing new patent laws but hopeless at compliance, said Francis Gurry, director general of the World Intellectual Property Organization.

BIO 2014: Public access to medicine at risk in US - report


The American public's access to new and effective medicines could be at risk as a result of the US Supreme Court's decisions in the Prometheus and Myriad cases, and the resulting guidance for examiners from the USPTO, according to a report presented to the 2014 BIO International Convention in San Diego today.

Indian Patent Office rejects anti-cancer drug patent


The Indian Patent Office has rejected a patent application for an anti-cancer drug for the second time, paving the way for generic versions to potentially enter the market.

Teva reaches settlement in ProAir patent case


Teva has reached a settlement in its patent battle with two pharmaceutical companies, ending all litigation over its ProAir HFA (albuterol sulfate) inhalation aerosol.

Victory for Bayer as CJEU grants safeners extra protection


Europe’s highest court has said that products used by agrochemical companies to help maintain plants can be given extended patent protection.

Holland & Knight nabs life sciences litigator


Holland & Knight LLP has expanded its IP practice group with the hire of patent litigator Howard Suh as partner.

Canada and Australia in new stem cell partnership

Australia, Canada16-06-2014

Stem cell research companies in Canada and Australia have teamed up to support increased research and development in both countries.

Merck to acquire Idenix for $3.85bn


Drug giant Merck is to acquire biopharmaceutical company Idenix for $24.50 per share, valuing the purchase at around $3.85 billion.

Showing 3331 to 3340 of 3632 results